Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Diffusion Pharmaceuticals Inc. (Charlottesville, VA)
Event Date 11/13/2019
Filing Date 11/13/2019

Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Entry into a Material Definitive Agreement; Other Events; and Financial Statements and Exhibits.
Download

File Section(s)

  1. FORM 8-K
  2. EXHIBIT 4.1
  3. EXHIBIT 4.2
  4. EXHIBIT 4.3
  5. EXHIBIT 4.4
  6. EXHIBIT 10.2
  7. EXHIBIT 99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.